| Phase II clinical trial of first-line combination of radiation followed by gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy for early-stage extranodal natural killer/T-cell lymphoma with unfavorable prognostic factors: The GREEN study | |
| Qi, Fei; Wang, Wei-Hu; Li, Ye-Xiong; Dong, Mei; He, Xiao-hui; Yang, Jianliang; Yang, Sheng; Fang, Hui; Chen, Bo; Qi, Shunan | |
| 2017 | |
| 会议名称 | JOURNAL OF CLINICAL ONCOLOGY |
| 会议日期 | 2017-05-20 |
| 收录类别 | CPCI-S |
| URL标识 | 查看原文 |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6369565 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Qi, Fei,Wang, Wei-Hu,Li, Ye-Xiong,et al. Phase II clinical trial of first-line combination of radiation followed by gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy for early-stage extranodal natural killer/T-cell lymphoma with unfavorable prognostic factors: The GREEN study[C]. 见:JOURNAL OF CLINICAL ONCOLOGY. 2017-05-20. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论